Europe — EMA
Ondansetron Renaudin (Ondansetron Hydrochloride Dihydrate)
GNH USA supplies Ondansetron Renaudin (Ondansetron), a 5‑HT3 antagonist for prevention of chemotherapy, postoperative and radiation‑induced nausea
Request sourcing
What is Ondansetron Hydrochloride Dihydrate?
Ondansetron Hydrochloride Dihydrate, the active ingredient in Ondansetron Renaudin, is a serotonin 5‑HT3 receptor antagonist presented as an intravenous solution for injection use. It prevents nausea and vomiting associated with chemotherapy, postoperative recovery, and radiation therapy.
GNH USA supplies Ondansetron Renaudin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.
What is Ondansetron Hydrochloride Dihydrate used for?
Ondansetron Renaudin is a serotonin 5‑HT3 antagonist used to control nausea and vomiting in several clinical settings.
- Chemotherapy‑induced nausea and vomiting: reduces the incidence and severity of nausea and vomiting in patients receiving cytotoxic chemotherapy. - Postoperative nausea and vomiting: prevents nausea and vomiting following surgical procedures. - Radiation‑induced nausea and vomiting: mitigates nausea and vomiting caused by therapeutic radiation.
What are the side effects of Ondansetron Hydrochloride Dihydrate?
Common Side Effects: - Headache: mild to moderate headache may occur. - Constipation: reduced bowel movements. - Diarrhea: loose stools. - Injection site pain: discomfort at the intravenous site.
Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm. - Severe allergic reaction: anaphylaxis with rash, swelling, and breathing difficulty. - QT interval prolongation: potential for serious heart rhythm changes.
What precautions apply to Ondansetron Hydrochloride Dihydrate?
Precautions should be taken when using Ondansetron Renaudin.
- Renal impairment: dose may need adjustment in severe renal dysfunction. - Hepatic impairment: use with caution in patients with liver disease. - Electrolyte imbalance: monitor potassium and magnesium levels. - Concomitant QT‑prolonging drugs: avoid combined use. - Pregnancy and lactation: assess risk versus benefit before prescribing. - Store at ambient temperature: keep in the original container, protect from light and moisture.
What does Ondansetron Hydrochloride Dihydrate interact with?
Ondansetron may interact with other medicines.
Major Interactions (Avoid): - Other QT‑prolonging agents: may increase risk of cardiac arrhythmia. - Apomorphine: can cause severe hypotension and loss of consciousness.
Moderate Interactions (Monitor Closely): - Anticholinergic drugs: may reduce antiemetic efficacy. - CYP3A4 inhibitors (e.g., ketoconazole): may increase ondansetron plasma levels. - CYP3A4 inducers (e.g., rifampin): may decrease ondansetron effectiveness.



